Science Corp., Another Braintech Startup Founded By Neuralink Alums, Raises $230M Series C

Science Corp.

, a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a $230 million Series C fundraise.

Lightspeed Venture Partners

Khosla Ventures

Y Combinator

IQT

and

Quiet Capital

were among the investors participating in the syndicated round. With the latest financing, Science Corp. says it has now raised $489 million since its 2021 inception. The Alameda, California-based company’s most recent raise previously was

a $104 million convertible note

led by Khosla last April.

While Science did not disclose its valuation in the announcement, it has been

reported

that the company is now valued at $1.5 billion.

The

Neuralink

competitor is working on both a brain-implant system and a retina implant to treat eye diseases. Notably, it was founded by

Max Hodak

, a co-founder of Neuralink, and

Alan Mardinly

, formerly part of Neuralink’s leadership team.

Science says it acquired MEMS, or microelectromechanical systems, facility assets in North Carolina, giving it the ability to manufacture in-house chip/MEMS for neural interface devices. Many competitors outsource manufacturing, which the company noted can slow down iteration or increase cost and risk.

The company says the funding will accelerate the commercialization of its PRIMA BCI retinal implant, with the expansion of its PRIMA clinical trial program to include other retinal diseases such as Stargardt disease and retinitis pigmentosa.

Big deals for neural interface startups

Billions of venture dollars have flowed into the neural interface and brain technology space

in recent years, with Neuralink being the most well-funded of the group. Last June, the

Elon Musk

-founded brain implant startup, announced a $650 million Series E funding round.

Other companies working on computer-brain interfaces have also raised significant venture backing, a review of Crunchbase data shows.

Another example is China’s

Stairway Medical

, a Neuralink competitor that raised a $48 million Series B funding round in February 2025,

reportedly

the largest-ever funding round for a startup in the field in that country. It also raised an unknown amount of capital in December. It’s unclear how much the company raised in previous venture rounds.

Meanwhile, yet another Neuralink competitor, Austin-based

Paradromics

, announced last June that it had performed its

first human surgery

using its Connexus Brain-Computer Interface. Paradromics has

raised a total of $108.6 million

in funding since its 2015 inception, according to Crunchbase data. Investors include

Fusion Fund

FJ Labs

15th Rock

Alpha Edison

and

DARPA

Related Crunchbase query:

Neuroscience Global Funding 2018 Through 2025